RxDoctor Payments Data

Harpal Khanuja, MD

Orthopaedic Surgery · Baltimore, MDNPI 1033187869

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (33.3%), speaking fees and royalties or licence payments — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 95.1% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $76,458, 8.3 times the $9,204 reported in 2019. Among orthopaedic surgery clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$149,818in general payments, 2019–2025

Across 142 payments — averaging $1055.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$142K
  • Zimmer Biomet$6K
  • Globus Medical$889
  • Nanovis LLC$200
  • Encore Medical, LP$178
  • Davol Inc.$133

What the payments were for

  • Royalty or licence$30,01120%
  • Consulting fees$49,85633%
  • Speaking & faculty fees$46,12531%
  • Travel & lodging$17,54712%
  • Food & beverage$6,1444%
  • Education$1340%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew108$142,500
Zimmer Biomet28$5,918
Globus Medical2$889
Nanovis LLC1$200
Encore Medical, LP2$178
Davol Inc.1$133

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$149,818 in reported general payments places this provider in the 90th percentile of 378 orthopaedic surgery providers in Maryland.

See all orthopaedic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$297,877
Medicare patients
586
Services billed
2,549

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin119$736
Meloxicam125$540
Naproxen12$291
Amoxicillin11$15

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →